SkinMedica scratches up $9.4M for anti-aging pharmaceuticals

June 16, 2009 | Camille Ricketts | Comments | |

SkinMedica, maker of specialized anti-aging treatments, has raised $9.4 million in equity and rights. It adds this amount to the $103.4 million in venture capital it previously brought in from a bevy of investors including Aisling Capital, Apax Partners, Domain Associates, EuclidSR Partners, HealthCare Ventures, Montagu Newhall Associates, Montreux Equity Partners, Split Rock Partners, St. Paul Venture Capital and Windamere Venture Partners.

Based in Carlsbad, Calif., the company last raised capital in 2006, bringing in $11.2 million in a fifth round of funding.

Next Story: Stitcher channels $100K for personalized radio
Previous Story: EMC and NetApp’s battle to buy Data Domain pays off for investors

Bookmark and Share

Photo of Camille Ricketts

About the Author, Camille Ricketts

Camille is the lead writer for GreenBeat. She came to VentureBeat from Google where she worked on its traditional platforms team, particularly in TV. Before that, she was a reporter for the Wall Street Journal in New York and London. Follow her on Twitter at @camillericketts, and follow VentureBeat on Twitter at @venturebeat.

With GreenBeat 2009, VentureBeat's all-star conference on all things Smart Grid, coming up in November, Camille will be expanding coverage of this exciting space. Stay up to date by following @greenbeat2009 on Twitter or by becoming a fan of the event on Facebook here.

  • Wine Bar Guy
    great post. amazing - $112M for anti-aging pharma. guess it makes sense w an aging population. reminds me of a great little movie - Saving Victor Vargas
  • anti-aging pharmaceuticals ?? can anyone give any genuine name ??